Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Amphastar Pharmaceuticals Inc (AMPH) USD0.0001

Sell:$18.07 Buy:$18.12 Change: $0.25 (1.40%)
NASDAQ:0.92%
Market closed |  Prices as at close on 27 November 2020 | Switch to live prices |
Sell:$18.07
Buy:$18.12
Change: $0.25 (1.40%)
Market closed |  Prices as at close on 27 November 2020 | Switch to live prices |
Sell:$18.07
Buy:$18.12
Change: $0.25 (1.40%)
Market closed |  Prices as at close on 27 November 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company focuses primarily on developing, manufacturing, marketing and selling generic and injectable, inhalation and intranasal products. The Company has two segments: finished pharmaceutical products and active pharmaceutical ingredients (API) products. The finished pharmaceutical products segment manufactures, markets and distributes enoxaparin, Cortrosyn, Amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes recombinant human insulin and porcine insulin. The Company also manufactures and sells insulin API. As of December 31, 2016, the Company manufactured and sold 19 products. As of December 31, 2016, the Company developed a portfolio of 15 generic abbreviated new drug applications (ANDAs) three generic biosimilar product candidates and six injectable and inhalation product candidates.

Contact details

Address:
11570 6th St
RANCHO CUCAMONGA
91730-6025
United States
Telephone:
+1 (909) 9809484
Website:
www.amphastar.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
AMPH
ISIN:
US03209R1032
Market cap:
$848.90 million
Shares in issue:
47.50 million
Sector:
Pharmaceuticals
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Mary Luo
    Chief Operating Officer, Chief Scientist and Chairman of the Board
  • Jack Zhang
    President, Chief Executive Officer, Chief Scientific Officer, Director
  • William Peters
    Chief Financial Officer, Senior Vice President, Treasurer and President of International Medication Systems, Limited
  • Rong Zhou
    Executive Vice President - Production Center and President of Armstrong Pharmaceuticals, Inc.
  • Jacob Liawatidewi
    Senior Vice President of Sales and Marketing, Corporate Administration Center, Corporate Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.